Mylan (MYL) Says EpiPen Pretax Profits Are 60% Higher Than it Told Congrees - DJ
- Top 10 News for 10/24 - 10/28: AT&T (T), Time Warner Make it Official; Margins Hamper Apple's Q4; Mergers Aplenty
- Wall St. falls as FBI to review more Clinton emails
- Clinton email problem resurfaces as FBI announces review
- ExxonMobil (XOM) Tops Q3 EPS by 5c; CapEx Light of Views
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Mylan (NASDAQ: MYL) Says EpiPen Pretax Profits Are 60% Higher Than it Told Congrees - DJ
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citron Research is long Mylan (MYL) - CNBC
- Booz Allen Hamilton (BAH) Announces External Review Following Arrest of Former Employee
- Corindus Vascular Robotics (CVRS) Reports FDA Clearance for Next-Gen Robotic System
Create E-mail Alert Related CategoriesCorporate News, Litigation, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!